2 CME
45 min
Uro-Oncology

First-Line Therapy for Urothelial Carcinoma

Dr. med. Nadine Biernath

Charité, Specialist in Urology, Senior consultant in interdisciplinary Uro-Oncology, Head of clinical tumour genetics

Prof. Dr. med. Jonas Busch

Vivantes Klinikum, Specialist in Urology, Head Physician at the Clinic for Urology Vivantes Klinikum Berlin
Learn more about the latest findings and treatment options for urothelial carcinoma, one of the most common urological cancers. The course provides comprehensive information on the incidence, prognosis and treatment, including the latest advances in immunotherapy and targeted therapy approaches such as enfortumab vedotin and pembrolizumab.
Please note: This is an AI-generated translation which has been manually checked and verified. If you have watched this course already in German, French or Italien you can watch the course but won't get any CME points.
This lecture is also available in: 

With the kind support of:
Write your awesome label here.

Weitere Urologie CME Fortbildungen